G01N33/5029

INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, PROGRAM, AND INFORMATION PROCESSING SYSTEM
20210217172 · 2021-07-15 ·

[Object] To evaluate the function related to absorption or release of a biological sample in more detail. [Solution] According to the present technology, an information processing device includes: a detection unit configured to detect at least one region of interest in at least one captured image among a plurality of captured images of a biological sample having different imaging times; a feature amount calculation unit configured to calculate a feature amount related to a change in the at least one region of interest in the plurality of captured images; and an evaluation value calculation unit configured to calculate an evaluation value for a function related to absorption or release of the biological sample on a basis of the feature amount.

Type X Collagen Assays and Methods of Use Thereof

The present invention provides methods for determining bone growth velocity comprising: (a) measuring an amount of a collagen X marker in a sample obtained from a subject in need thereof; and (b) comparing the amount of collagen X marker measured in step (a) with a collagen X marker standard curve, wherein the amount of collagen X marker is measured using at least two reagents. In an embodiment, there is at least one capture reagent and at least one detection reagent. In a preferred embodiment for measuring CXM, the capture reagent is the aptamer SOMA1 and the detection reagent is the monoclonal antibody mAb X34. The present invention further provides methods for treating diseases, disorders or conditions comprising receiving an identification of an amount of CXM in a sample, wherein the amount of CXM has been identified using a combination of SOMA1 and mAb X34 as CXM-binding reagents, and administering a treatment in light of the amount of CXM in the sample.

LEUKOCYTE RECRUITMENT IN INFECTIOUS DISEASE
20210239678 · 2021-08-05 ·

The present disclosure relates to assays, including but not limited to, leukocyte adhesive function assays (LAFA), devices and/or methods of using such assays. The present disclosure also relates to the uses of the disclosed embodiment in diagnostic, analytic and/or prognostic applications, particularly for diagnostic, analytic and/or prognostic applications in relation to diseases associated with abnormal host immune responses.

METHOD AND DEVICE FOR EARLY CANCER SCREENING

The present disclosure provides a device for assessing adhesion strength of a cancer cell and methods of using the same.

VERTICAL THERMAL GRADIENT EQUIPMENT AND METHOD FOR PROGRESSIVE SPERM SORTING

This disclosure relates to an apparatus and method for sorting motile sperms from crude semen. the enrichment of a population of spermatozoa with capacitated spermatozoa can be achieved by providing a 1-to-4-degree vertical temperature difference in combination with the swim-up method.

CONTACTLESS INSPECTION OF REPRODUCTIVE CELLULAR STRUCTURES USING OPTICAL MEASUREMENT OF BIOMECHANICAL PROPERTIES
20210270810 · 2021-09-02 ·

A method of measuring at least one biomechanical property of a reproductive cellular structure is provided. The method includes illuminating the reproductive cellular structure with radiation; detecting at least a portion of radiation scattered from the illuminated reproductive cellular structure; analyzing a frequency spectrum of the detected scattered radiation to identify at least one Brillouin frequency shift in the frequency spectrum; and determining the at least one biomechanical property based on the Brillouin frequency shift. The method further includes determining a viability index of the reproductive cellular structure based on the at least one biomechanical property.

Multi-component in vitro system to deduce cell signaling pathways by electronic stimulation patterns

Disclosed herein are cell culture analog devices, systems and methods for applying stimuli to components containing different cell types and recording the cell responses before, during, and after a stimulus (for example, a drug, metabolite, toxin, or electrical stimulus) is introduced. Responses can be stored to a database and compared to previous results. By analyzing how each cell type responds to various stimulation parameters, for example, by using multivariate analyses, cell signaling pathway information can be determined or new pathways can be discovered. In some implementations, an individual component interfaces with a specific cell type. This facilitates readout of the cell response to the stimulation. Various components can also interface with each other, such that the behavior of one cell type can affect a cell type in another component. Once assembled, the system is plugged into readout electronics and a programmable electrical stimulator.

MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND CANCER

Disclosed herein are methods of treating, reducing the incidence of, or preventing one or more activities in or of a cancer cell, methods of treating, reducing the incidence of, or preventing migration or metastasis of a cancer cell, methods of treating, reducing the incidence of, or preventing a cancer by reducing tumor associated macrophages (TAMs) or their migration, and methods of treating, reducing the incidence of, or preventing a cancer (including metastatic cancer), for example, with an inhibitor of Motile Sperm Domain containing Protein 2 (MOSPD2). Also disclosed are inhibitors of MOSPD2 (e.g., anti-MOSPD2 antibodies or antigen binding fragments thereof) and pharmaceutical compositions containing MOSPD2 inhibitors. Also disclosed are methods for the prediction, diagnosis, or prognosis of cancer, cancer metastasis, tumor progression, or tumor invasiveness in a subject.

OLIGONUCLEIC ACID VARIANT LIBRARIES AND SYNTHESIS THEREOF
20210040476 · 2021-02-11 ·

Disclosed herein are methods for the generation of highly accurate oligonucleic acid libraries encoding for predetermined variants of a nucleic acid sequence. The degree of variation may be complete, resulting in a saturated variant library, or less than complete, resulting in a selective library of variants. The variant oligonucleic acid libraries described herein may designed for further processing by transcription or translation. The variant oligonucleic acid libraries described herein may be designed to generate variant RNA, DNA and/or protein populations. Further provided herein are method for identifying variant species with increased or decreased activities, with applications in regulating biological functions and the design of therapeutics for treatment or reduction of disease.

Membrane for reconstructed tissue comprising pores of several diameters
10920184 · 2021-02-16 · ·

The present invention relates to membranes comprising at least two types of porosity: a porosity of small size but of high density, allowing for the support and nutrition of culture cells in such a way as to obtain a reconstructed tissue model, anda porosity of large size but of low density, allowing for the circulation of some cell types and the passage of cytoplasmic extensions from one compartment to another.